This model is standard across many telehealth GLP-1 providers, but it does limit the depth of clinical interaction, particularly for patients with autoimmune conditions or complex medical histories that benefit from real-time conversation
Semaglutide May NOT Be Ideal If: You have already used GLP-1 medications with limited results You have severe insulin resistance or metabolic dysfunction You require more aggressive weight-loss support You are pregnant, breastfeeding, or have contraindicated medical conditions This injection is not meant for minor weight loss (57 kg) Who Is an Ideal Candidate for Tirzepatide Weight-Loss Treatment Tirzepatide is a next-generation weight-loss injection that targets both appetite and metabolic function
| How these medications work | Head-to-head clinical evidence | Side effects and tolerability | Practical differences | Cost and access in the UK | Who might prefer each option
Here are some side effects reported that some people are unable to tolerate: Gastrointestinal Effects Some individuals may experience mild gastrointestinal side effects, including nausea, vomiting, or diarrhea, especially during the initial stages of treatment
They are very personable and knowledgeable about weight loss and nutrition
